Dermatological Manifestations of Emergent Viruses. Part I: Common and Vaccine-Preventable Viral Infections.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 42764130.
- Also identified by DOI 10.1016/j.jaad.2026.09.054.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Viral infections frequently present with mucocutaneous manifestations that may provide diagnostic clues and guide timely management. However, the expanding therapeutic landscape and evolving public health recommendations highlight the need for an updated evidence-based review for dermatologists. Herein, we summarize the epidemiology, clinical presentation, diagnosis, management, and prevention of common and vaccine-preventable viral infections with dermatologic relevance, including Coronavirus Disease-2019 (COVID-19), mpox, measles, and rubella. Advances in antiviral therapies, immunomodulators, vaccination, and post-exposure prophylaxis have improved outcomes for several infections. Recognition of characteristic skin findings, familiarity with current diagnostic approaches, and implementation of evidence-based prevention strategies are essential for early diagnosis, appropriate treatment, and limiting disease transmission.